Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label mass balance and pharmacokinetics study of [14C]-BIA 9-1067 in healthy male volunteers
NL-OMON35986Active, not recruiting
- Sponsor
- BIAL
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of opicapone in Parkinson's disease (PD), sponsored by BIAL. Primary endpoints: Radiokinetics and Pharmacokinetics. Started Mar 2011; status: active, not recruiting.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON35986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35986.